Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla

In this paper a new method is presented for the relative assessment of brain iron concentrations based on the evaluation of T2 and T2* ‐weighted images. A multiecho sequence is employed for rapid measurement of T2 and T2*, enabling calculation of the line broadening effect ( T2′). Several groups have failed to show a correlation between T2 and brain iron content. However, quantification of T2′, and the associated relaxation rate R2′, may provide a more specific relative measure of brain iron concentration. This may find application in the study of brain diseases, which cause associated changes in brain iron levels. A new method of field inhomogeneity correction is presented that allows the separation of global and local field inhomogeneities, leading to more accurate T2* measurements and hence, T2′ values. The combination of T2*, and T2‐weighted MRI methods enables the differentiation of Parlkinson's disease patients from normal age‐matched controls based on differences in iron content within the substantia nigra.

[1]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[2]  J. Degroot,et al.  Magnetic resonance imaging of the midbrain in Parkinson's disease , 1986, Annals of neurology.

[3]  J. Frahm,et al.  Direct FLASH MR imaging of magnetic field inhomogeneities by gradient compensation , 1988, Magnetic resonance in medicine.

[4]  D Gadian,et al.  Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[5]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[6]  R I Grossman,et al.  Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.

[7]  R. Henkelman,et al.  T2 values in the human brain: comparison with quantitative assays of iron and ferritin. , 1989, Radiology.

[8]  J. Pujol,et al.  Biological significance of iron-related magnetic resonance imaging changes in the brain. , 1992, Archives of neurology.

[9]  Yu. A. Brychkov,et al.  Integrals and series , 1992 .

[10]  A New Frontier of Blood Imaging Using Susceptibility Effect and Tailored RF Pulses , 1992, Magnetic resonance in medicine.

[11]  Ravi S. Menon,et al.  Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. , 1993, Biophysical journal.

[12]  P. Boesiger,et al.  T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.

[13]  R. Ordidge,et al.  Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.